Parkinson'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a diagnosis of Parkinson's disease 2. Patients received treatments with anti-Parkinson's drugs when participating in the study 3. Patients being able to answer the online survey 4. Patients who consent to the study spring from their own free will
Exclusion criteria
Exclusion criteria: 1. Patients being unable to answer the survey themselves or without someone who manipulates instead of patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relative importance of attribute and preference weights of levels for anti-Parkinson's drugs | — |
Secondary
| Measure | Time frame |
|---|---|
| The subgroup analysis of primary outcomes | — |
Countries
Japan
Contacts
Eisai Co., Ltd. Medical Headquarters